Eagle Pharmaceuticals, Inc. to Discuss Third Quarter 2016 Financial Results on November 9, 2016
October 26 2016 - 4:30PM
Business Wire
Eagle Pharmaceuticals, Inc. ("Eagle" or “the Company”)
(Nasdaq:EGRX) announced today that the Company will release its
2016 third quarter financial results on Wednesday, November 9,
2016, before the market opens.
Scott Tarriff, President and Chief Executive Officer, and David
E. Riggs, Chief Financial Officer, will host a conference call to
discuss the results as follows:
Date Wednesday, November 9, 2016 Time 8:30 A.M. EST
Toll free (U.S.) 888-632-3384 International 785-424-1675 Webcast
(live and replay)
www.eagleus.com, under the “Investor
Relations” section
A replay of the conference call will be available for one week
after the call's completion by dialing 800-374-1375 (US) or
402-220-0682 (International) and entering conference call ID
EGRXQ316. The webcast will be archived for 30 days at the
aforementioned URL.
About Eagle Pharmaceuticals, Inc.
Eagle is a specialty pharmaceutical company focused on
developing and commercializing injectable products that address the
shortcomings, as identified by physicians, pharmacists and other
stakeholders, of existing commercially successful injectable
products. Eagle’s strategy is to utilize the FDA's 505(b)(2)
regulatory pathway. Additional information is available on the
company’s website at www.eagleus.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161026006163/en/
Investor Relations for Eagle Pharmaceuticals, Inc:In-Site
Communications, Inc.Lisa M. Wilson, President, 212-452-2793
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Eagle Pharmaceuticals (NASDAQ:EGRX)
Historical Stock Chart
From Apr 2023 to Apr 2024